Contraceptive risk : the FDA, Depo-Provera, and the politics of experimental medicine
- William Green.
- New York : New York University Press, 
- Copyright notice
- Physical description
- xiii, 322 pages ; 23 cm.
- Biopolitics (New York, N.Y.)
- Green, William, 1950- author.
- Includes bibliographical references and index.
- Introduction: The odyssey of Depo-Provera
- The Grady Hospital study : the corruption of contraceptive research
- The twenty-five-year FDA approval controversy : cancer and the politics of acceptable risk
- Contraceptive chaos : unapproved use and Upjohn v. MacMurdo
- Marketing approval and litigation : osteoporosis and the realities of medical risk
- Chemical castration : the John Hopkins Clinic and People v. Gauntlett
- Conclusion: Contraceptive drug risk failure, human dignity, and a duty to act.
- Publisher's Summary
- The story of Depo-Provera joins the national struggle over the drug's FDA approval to the state legal issues raised by its contraceptive and criminal justice uses. Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders. Contraceptive Risk is William Green's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development.Contraceptive Risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk.
(source: Nielsen Book Data)9781479876990 20170821
- Publication date
- Copyright date
- Title Variation
- FDA, Depo-Provera, and the politics of experimental medicine
- Food and Drug Administration, Depo-Provera, and the politics of experimental medicine
- Biopolitics : medicine, technoscience, and health in the 21st century
- 9781479876990 (cl ; alk. paper)
- 1479876992 (cl ; alk. paper)
- 9781479836987 (pb ; alk. paper)
- 1479836982 (pb ; alk. paper)
Browse related items
Start at call number: